Salarius Pharmaceuticals to Present Trial in Progress Poster at ASCO20 Virtual Scientific Program

Author's Avatar
May 27, 2020
Article's Main Image

Patient Enrollment Continues in Phase 1/2 Dose Escalation Trial for Seclidemstat in Relapsed or Refractory Ewing Sarcoma